Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Bertagna

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Genetic testing in pheochromocytoma or functional paragangliomaLaurence Amar, Jérôme Bertherat, Eric Baudin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2010
Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotypeRossella Libé, Anelia Horvath, Delphine Vezzosi, et al.
Cancer Cell|December 30, 2019
Pangenomic Classification of Pituitary Neuroendocrine TumorsMario Neou, Chiara Villa, Roberta Armignacco, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2011
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumorsWiebke Arlt, Michael Biehl, Angela E Taylor, et al.
The New England Journal of Medicine|November 29, 2013
ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndromeGuillaume Assié, Rossella Libé, Stéphanie Espiard, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2015
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional ConsequencesStéphanie Espiard, Ludivine Drougat, Rossella Libé, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2015
Pregnancy in Women Previously Treated for an Adrenocortical CarcinomaPauline de Corbière, Katrin Ritzel, Laure Cazabat, et al.
Nature Genetics|June 13, 2006
A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasiaAnelia Horvath, Sosipatros Boikos, Christoforos Giatzakis, et al.
The Journal of Clinical Endocrinology and Metabolism|July 26, 2013
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paragangliomaSégolène Hescot, Sophie Leboulleux, Laurence Amar, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Genetic testing in pheochromocytoma or functional paragangliomaLaurence Amar, Jérôme Bertherat, Eric Baudin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2010
Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotypeRossella Libé, Anelia Horvath, Delphine Vezzosi, et al.
Cancer Cell|December 30, 2019
Pangenomic Classification of Pituitary Neuroendocrine TumorsMario Neou, Chiara Villa, Roberta Armignacco, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2011
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumorsWiebke Arlt, Michael Biehl, Angela E Taylor, et al.
The New England Journal of Medicine|November 29, 2013
ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndromeGuillaume Assié, Rossella Libé, Stéphanie Espiard, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2015
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional ConsequencesStéphanie Espiard, Ludivine Drougat, Rossella Libé, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2015
Pregnancy in Women Previously Treated for an Adrenocortical CarcinomaPauline de Corbière, Katrin Ritzel, Laure Cazabat, et al.
Nature Genetics|June 13, 2006
A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasiaAnelia Horvath, Sosipatros Boikos, Christoforos Giatzakis, et al.
The Journal of Clinical Endocrinology and Metabolism|July 26, 2013
One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paragangliomaSégolène Hescot, Sophie Leboulleux, Laurence Amar, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
Pageof 13